Isatin binding proteins in rat brain: In situ imaging, quantitative characterization of specific [3H]isatin binding, and proteomic profiling

Journal of Neuroscience Research

Volumn 87, Issue 12, 2009, Pages 2763-2772

  Crumeyrolle Arias, Michele ^a   Buneeva, Olga ^b   Zgoda, Victor ^b   Kopylov, Arthur ^b   Cardona, Ana ^c   Tournaire, Marie Claude ^d   Pozdnev, Vladimir ^b   Glover, Vivette ^e   Medvedev, Alexei ^b  

^a Groupe Enzymologie Moléculaire et Fonctionnelle   (France)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

3H isatin binding; Brain; Is situ imaging; Isatin binding proteins; Proteomics

Indexed keywords

5 AMINOCAPROYL ISATIN SEPHAROSE; BINDING PROTEIN; CYTOSKELETON PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; ISATIN; ISATIN BINDING PROTEIN; ISATIN TRIDIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN HOMOGENATE; BRAIN REGION; CELL LYSATE; COLD; CONTROLLED STUDY; EXPERIMENTAL RAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS; IN SITU HYBRIDIZATION; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; STRESS;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BRAIN; BRAIN CHEMISTRY; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (NADP+); HYPOTHALAMUS; ISATIN; KINETICS; MALE; NERVE TISSUE PROTEINS; PROTEIN BINDING; PROTEOMICS; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; TRITIUM;

EID: 70449469388     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22104     Document Type: Article

References (76)

1. Aksenov M, Aksenova M, Butterfield DA, Markesbery WR. 2000. Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J Neurochem 74:2520-2527. (Pubitemid 30314229)
2. Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y, Young TA, Bullard J, Yokoe H, Webster MJ, Knable MB, Brockman JA. 2005. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 58:85-96. (Pubitemid 41008124)
3. Asryants RA, Dushenkova IV, Nagradova NK. 1985. Determination of Sepharose-bound protein with Coomassie brilliant blue G 250. Anal Biochem 151:571-574.
4. Bates G. 2003. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361:1642-1644. (Pubitemid 36579005)
5. Benitez-King G. 2006. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 40:1-9.
6. Berg D, Holzmann C, Riess O. 2003. 14-3-3 Proteins in the nervous system. Nat Rev Neurosci 4:752-762.
7. Bhattacharya SK, Acharya SB. 1993. Further investigation on the anxiogenic effects of isatin. Biogenic Amines 9:453-463.
8. Bhattacharya SK, Ramnathan M, Glover V. 2000. Intraventricular administration of isatin in rats: antidiuretic dipsogenic, anorexiant and emetic effects. Biogenic Amines 16:63-71. (Pubitemid 32058703)
9. Bizzozero OA, Reyes S, Ziegler J, Smerjac S. 2007. Lipid peroxidation scavengers prevent the carbonylation of cytoskeletal brain proteins induced by glutathione depletion. Neurochem Res 32:2114-2122 (Pubitemid 350059855)
10. Botia B, Seyer D, Ravni A, Bénard M, Falluel-Morel A, Cosette P, Jouenne T, Fournier A, Vaudry H, Gonzalez BJ, Vaudry D. 2008. Peroxiredoxin 2 is involved in the neuroprotective effects of PACAP in cultured cerebellar granule neurons. J Mol Neurosci (in press).
11. Brockstedt E, Rickers A, Kostka S, Laubersheimer A, Dorken B, Wittmann- Liebold B, Bommert K, Otto A. 1998. Identification of apoptosis- associated proteins in a human Burkitt lymphoma cell line. J Biol Chem 273:28057-28064.
12. Butterfield DA, Perluigi M, Sultana R. 2006. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol 545:39-50. (Pubitemid 44215876)
13. Cane A, Tournaire M-C, Barritault D, Crumeyrolle-Arias M. 2000. The endogenous oxindoles 5-hydroxyoxindole and isatin are antiproliferative and proapoptotic. Biochem Biophys Res Commun 276:379-384.
14. Castegna A, Aksenov M, Thongboonkerd VB, Klein J, Pierce WM, Booze R, Markesbery WR, Butterfeld DA. 2002. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase- related protein 2, a-enolase and heat shock cognate 71. J Neurochem 82:1524-1532.
15. Chapman JG, Magee WP, Stukenbrok HA, Beckius GE, Milici AJ, Tracey WR. 2002. A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)- 5-[1-(2- methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury. Eur J Pharmacol 456:59-68.
16. Charpak G, Dominic W, Zaganidis N. 1989. Optical imaging of the spatial distribution of beta-particles emerging from surfaces. Proc Natl Acad Sci U S A 86:1741-1745.
17. Chen A, Liao WP, Lu Q, Wong WSF, Wong PT-H. 2007a. Upregulation of dihydropyrimidinase-related protein 2, spectrin a II chain, heat shock cognate protein 70 pseudogene 1 and tropomodulin 2 after focal cerebral ischemia in rats-a proteomics approach. Neurochem Int 50:1078-1086. (Pubitemid 46962809)
18. Chen R-W, Williams AJ, Liao Z, Yao C, Tortella FC, Dave JR. 2007b. Broad spectrum neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation. Neurosci Lett 418:165-169. (Pubitemid 46636000)
19. Chen W-Q, Diao WF, Viidik A, Skalicky M, Höger H, Lubec G. 2008. Modulation of the hippocampal protein machinery in voluntary and treadmill exercising rats. Biochim Biophys Acta 1784:555-562.
20. Chuang DM, Hough C, Senatorov VV. 2005. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol 45:269-290 (Pubitemid 40261806)
21. Crumeyrolle-Arias M, Latouche J, Laniece P, Charon Y, Tricoire H, Valentin L, Roux P, Mirambeau G, Leblanc P, Fillion G. 1994. In situ characterization of GnRH receptors: use of two radioimagers and comparison with quantitative autoradiography. J Recept Res 14:251-265.
22. Crumeyrolle-Arias M, Jafarian-Tehrani M, Cardona A, Edelman L, Roux P, Laniece P, Charon Y, Haour F. 1996. Radioimagers as an alternative to film autoradiography for in situ quantitative analysis of 125I-ligand receptor binding and pharmacological studies. Histochem J 28:801-809. (Pubitemid 26414170)
23. 3H]isatin in rat brain. J Neurochem 84:618-620.
24. Dhanasekaran M, Albano CB, Pellet L, Karuppagounder SS, Uthayathas S, Suppiramaniam V, Brown-Borg H, Ebadi M. 2008. Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine-induced neurotoxicity. Neurochem Res 33:980-984.
25. Di Stasi AMM, Mallozzi C, Macchia G, Maura G, Petrucci TC, Minetti M. 2002. Peroxynitrite affects exocytosis and SNARE complex formation and induces tyrosine nitration of synaptic proteins. J Neurochem 82:420-429. (Pubitemid 34774633)
26. Diederich L, Fotedar A, Fotedar R. 1998. Proteolytic cleavage of retinoblastoma protein upon DNA damage and Fas-mediated apoptosis. Cell Biol Toxicol 14:133-140. (Pubitemid 28123603)
27. Dubois-Dauphin M, Theler JM, Zaganidis N, Dominic W, Tribollet E, Pévet P, Charpak G, Dreifuss JJ. 1991. Expression of vasopressin receptors in hamster hypothalamus is sexually dimorphic and dependent upon photoperiod. Proc Natl Acad Sci U S A 88:11163-11167. (Pubitemid 21916000)
28. Eng LF, Ghirnikar RS, Lee YL. 2000. Glial fibrillary acidic protein (GFAP): thirty-one years. Neurochem Res 25:1439-1451.
29. Garbis S, Lubec G, Fountoulakis M. 2005. Limitations of current proteomics technologies. J Chromatogr A1077:1-18.
30. Gibson TR, Wildey GM, Manaker S, Glembotski CC. 1986. Autoradiographic localization and characterization of atrial natriuretic peptide binding sites in the rat central nervous system and adrenal gland. J Neurosci 6:2004-2011. (Pubitemid 16064966)
31. Glatt SJ, Everall IP, Kremen WS, Corbeil J, Sasikh R, Khanlou N, Han M, Liew C-C, Tsuang MT. 2005. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci U S A 102:15533-15538. (Pubitemid 41528092)
32. Glover V, Medvedev A, Sandler M. 1995. Isatin is a potent endogenous antagonist of guanylate cyclase-coupled atrial natriuretic peptide receptors. Life Sci 57:2073-2079.
33. Glover V, Bhattacharya SK, Chakrabarti A, Sandler M. 1998. The pharmacology of isatin: a brief review. Stress Med 14:225-229.
34. Guil S, Long JC, Caceres JF. 2006. hnRNP A1 relocalization to the stress granules reflects a Role in the stress response. Mol Cell Biol 26:5744-5758. (Pubitemid 44134331)
35. Hamaue N, Yamazaki N, Terado M, Minami M, Ohno K, Ide H, Ogata A, Honma S, Tashiro K. 2000. Urinary isatin concentrations in patients with Parkinson's disease determined by a newly developed HPLC-UV method. Res Commun Mol Pathol Pharmacol 108:63-73. (Pubitemid 33104160)
36. Harjes P, Wanker EE. 2003. The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 28:425-433. (Pubitemid 36976745)
37. Igosheva N, Matta S, Glover V. 2004. Effect of acute stress and gender on isatin in rat tissues and serum. Physiol Behav 80:665-668. (Pubitemid 38230965)
38. Igosheva N, Lorz ,C, O'Conner E, Glover V, Mehmet H. 2005. Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cells. Neurochem Int 47:216-224. (Pubitemid 40848684)
39. Ishihama Y, Sato T, Tabata T, Miyamoto N, Sagane K, Nagasu T, Oda Y. 2005. Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards. Nat Biotechnol 23:617-621. (Pubitemid 41724902)
40. Ishitani R, Tajima H, Takata H, Tsuchiya K, Kuwae T, Yamada M, Takahashi H, Tatton NA, Katsube N. 2003. Proapoptotic protein glyceraldehyde- 3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs. Prog Neuropsychopharmacol Biol Psychiatry 27:291-301. (Pubitemid 36351496)
41. Ivanov Yu D, Panova NG, Gnedenko OV, Buneeva OA, Medvedev AE, Archakov AI. 2002. Study of the tissue and subcellular distribution of isatin-binding proteins with optical biosensor. Vopr Med Khim 48:73-83.
42. Kapp EA, Schutz F, Connolly LM, Chakel JA, Meza JE, Miller CA, Fenyo D, Eng JK, Adkins JN, Omenn GS, Simpson RJ. 2005. An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: sensitivity and specificity analysis. Proteomics 5:3475-3490. (Pubitemid 41192052)
43. Kim S-Y, Marekov L, Bubber P, Browne SE, Stavrovskaya I, Lee J, Steinert PM, Blass JP, Beal MF, Gibson GE, Cooper AJL. 2005. Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain. Neurochem Res 30:1245-1255. (Pubitemid 41772271)
44. Klivenyi P, Starkov AA, Calingasan NY, Gardian G, Browne SE, Yang L, Bubber P, Gibson GE, Patel MS, Beal MF. 2004. Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. J Neurochem 88:1352-1360. (Pubitemid 38366910)
45. Lanièce P, Charon Y, Mallet J, Dumas S, Mastripolito R, Pinot L, Tricoire H, Valentin L. 1994. HRRI: a high resolution radioimager for fast, direct quantification in in situ hybridisation experiments. Biotechniques 17:338-345.
46. Lee D, Long SA, Murray JH, Adams JL, Nuttall ME, Nadeau DP, Kikly K, Winkler JD, Sung C-M, Ryan MD, Levy MA, Keller PM, DeWolf WE Jr. 2001. Potent and selective nonpeptide inhibitors of caspases 3 and 7. J Med Chem 44:2015-2026. (Pubitemid 32884524)
47. Martin SJ, O'Brien GA, Nishioka WK, McGahon AJ, Mahboubi A, Saido TC, Green DR. 1995. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 270:6425-6428.
48. Mawatari K, Segawa M, Masatsuka R, Hanawa Y, Iinuma F, Watanabe M. 2001. Fluorimetric determination of isatin in human urine and serum by liquid chromatography postcolumn photoirradiation. Analyst 126:33-36. (Pubitemid 32183358)
49. Mazzola JL, Sirover MA. 2002. Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders. Neurotoxicology 23:603-609.
50. McEwen BS. 2007. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87:873-904.
51. Medvedev AE, Clow A, Sandler M, Glover V. 1996. Isatin - a link between natriuretic peptides and monoamines? Biochem Pharmacol 52:385-391.
52. Medvedev A, Byssygina O, Pyatakova N, Glover V, Severina IS. 2002. Effect of isatin on nitric oxide-stimulated soluble guanylate cyclase from human platelets. Biochem Pharmacol 63:763-766. (Pubitemid 34457709)
53. 3H]isatin binding sites in rat brain. Brain Res 1042:119-124.
54. Medvedev A, Igosheva N, Crumeyrolle-Arias M, Glover V. 2005b. Isatin: role in stress and anxiety. Stress 8:175-183.
55. Medvedev A, Buneeva O, Gnedenko O, Fedchenko V, Medvedeva M, Ivanov Yu, Glover V, Sandler M. 2006. Isatin interaction with glyceraldehyde- 3-phosphate dehydrogenase, a putative target of neuroprotective drugs: partial agonism with deprenyl. J. Neural Transm Suppl 71:195-203.
56. Medvedev A, Buneeva O, Glover V. 2007. Biological targets for isatin and its analogues: implications for therapy. Biol Targets Ther 1:151-162.
57. Merkulova T, Lucas M, Jabet C, Lamande N, Rouzeau J-D, Gros F, Lazar M, Keller A. 1997. Biochemical characterization of the mouse muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins. Biochem J 323:791-800. (Pubitemid 27202351)
58. Pandeya SN, Smitha S, Jyoti M, Sridhar SK. 2005. Biological activities of isatin and its derivatives. Acta Pharmacol 55:27-46. (Pubitemid 40562617)
59. Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, Bonetto V, Casoni F, Carrozzo R, Federici G, Piemonte F. 2003. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia. J Biol Chem 278:42588-42595.
60. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates,4th ed. San Diego: Academic Press.
61. Pekny M, Pekna M. 2004. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 204:428-437. (Pubitemid 39468154)
62. Poon HF, Vaishnav RA, Getchell TV, Getchell ML, Butterfield DA. 2006. Quantitative proteomics analysis of differential protein expression and oxidative modification of specific proteins in the brains of old mice. Neurobiol Aging 27:1010-1019.
63. Pozdnev VF. 1994. Activation of carboxylic acids by pyrocarbonates. Synthesis of arylamides of N-protected amino acids and small peptides using dialkyl pyrocarbonates as condensing reagents. Int J Peptide Prot Res 44:36-48.
64. Reed TT, Pierce WM Jr, Turner DM, Markesbery WR, Butterfield DA. 2008. Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule. J Cell Mol Med [E-pub 21 Aug 2008].
65. Sandler M, Medvedev AE, Panova NG, Matta S, Glover V. 2000. Isatin: from monoamine oxidase to natriuretic peptides. In: Magyar K, Visi ES, editors. Milestones in monoamine oxidase research: discovery of (-) deprenyl. Budapest: Meditcina Publishing House Co. p 237-251.
66. Santpere G, Puig B, Ferrer I. 2007. Oxidative damage of 14-3-3 zeta and gamma isoforms in Alzheimer's disease and cerebral amyloid angiopathy. Neuroscience 146:1640-1651. (Pubitemid 46805117)
67. 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J Neurosci 12:1977-1999.
68. Shearwin K, Nanhua C, Masters C. 1990. Interactions between glycolytic enzymes and cytoskeletal structure - the influence of ionic strength and molecular crowding. Biochem Int 21:53-60. (Pubitemid 20181142)
69. Tatton W, Chalmers-Redman R, Tatton N. 2003. Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B. J Neural Transm 110:509-515. (Pubitemid 36543282)
70. Tozawa Y, Ueki A, Manabe S, Matsushima K. 1998. Stress-induced increase in urinary isatin excretionin rats: reversal by both dexamethasone and alpha-methyl-p-tyrosine. Biochem Pharmacol 56:1041-1046. (Pubitemid 28454570)
71. Verma M, Pandeya SN, Singh KN, Stables JP. 2004. Anticonvulsant activity of Schiff bases of isatin derivatives. Acta Pharmacol 54:49-56. (Pubitemid 38524314)
72. Waingeh VF, Gustafson CD, Kozliak EI, Lowe SL, Knull HR, Thomasson KA. 2006. Glycolytic enzyme interactions with yeast and skeletal muscle F-actin. Biophys J 90:1371-1384.
73. Walker JM, editor. 2002. The protein protocols handbook. Totowa, NJ: Humana Press Inc.1176 p.
74. Watkins P, Clow A, Glover V, Halket J, Przyborowska A, Sandler M. 1990. Isatin, regional distribution in rat brain and tissues. Neurochem Int 17:321-323. (Pubitemid 20252599)
75. Wirths O, Breyhan H, Marcello A, Cotel M-C, Brück W, Bayer TA. 2008. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease. Neurobiol Aging [Jul 25 E-pub ahead of print].
76. Witzmann FA, Arnold RJ, Bai F, Hrncirova P, Kimpel MW, Mechref YS, McBride WJ, Novotny MV, Pedrick NM, Ringham HN, Simon JR. 2005. A proteomic survey of rat cerebral cortical synaptosomes. Proteomics 5:2177-2201.